Identification of HLA-B*1566

Area of Science:

• Immunogenetics
• Molecular Biology
• Human Leukocyte Antigen (HLA) research

Background:

• The Human Leukocyte Antigen (HLA) system plays a crucial role in immune response.
• Allelic variations within HLA genes, such as B*15, contribute to diverse immune profiles.
• Understanding novel polymorphisms is essential for transplant compatibility and disease association studies.

Purpose of the Study:

• To characterize a newly identified polymorphism within the B*15 allele.
• To determine the nucleotide and amino acid changes associated with this novel allele.
• To investigate the potential evolutionary origins and implications of this genetic variation.

Main Methods:

• Nucleotide sequencing was employed to identify and define the novel polymorphism.
• Comparison of the new allele's sequence with known HLA alleles was performed.
• Structural analysis focused on the location and potential functional impact of the amino acid substitution.

Main Results:

• A novel B*15 allele, designated B*1566, was identified.
• B*1566 exhibits a C-to-G nucleotide substitution at position 272.
• This results in an amino acid change from serine to cysteine at residue 67, located in the alpha1 helix of the HLA-B molecule.

Conclusions:

• The identified polymorphism in B*1566 results in a significant amino acid alteration at a critical residue.
• Residue 67 is part of the HLA-B peptide-binding groove, suggesting potential functional consequences.
• The mutation's presence in other HLA alleles suggests a possible role for interallelic recombination in its evolution.